Monografie
Biocompatible and precise branched oligomers for pDNA and siRNA delivery
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Diss., 2013
- Identifier
-
1037076346
Thema
Krebs; Onkologie; Hochschulschrift
Beteiligte Personen und Organisationen
Salcher, Edith
Wagner, Ernst
Wagner, Ernst
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:53 MEZ
Objekttyp
- Monografie
Beteiligte
- Salcher, Edith
- Wagner, Ernst
Ähnliche Objekte (12)
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Nanocarriers based on sequence-defined oligomers for tumor-targeted siRNA and miRNA delivery
Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery
Precise and multifunctional conjugates for targeted siRNA delivery
Molecular evolution assays reveal novel targets and mechanisms of drug resistance
Molecular imaging and radionuclide therapy in non-thyroidal tumors after mesenchymal stem cell- mediated sodium/iodide symporter (NIS) gene transfer
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
Targeted RNAi and pDNA based therapy for gastrointestinal tumors
Novel insights into the role of microRNAs in chemoresistance, tumor progression and cancer therapy
Proton-sponge activity and receptor-targeting of sequence-defined nucleic acid carriers
Treatment of cancer with combined chemo-gene therapy based on TNFα polyplexes and liposomal doxorubicine
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Nanocarriers based on sequence-defined oligomers for tumor-targeted siRNA and miRNA delivery
Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery
Precise and multifunctional conjugates for targeted siRNA delivery
Molecular evolution assays reveal novel targets and mechanisms of drug resistance
Molecular imaging and radionuclide therapy in non-thyroidal tumors after mesenchymal stem cell- mediated sodium/iodide symporter (NIS) gene transfer
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
Targeted RNAi and pDNA based therapy for gastrointestinal tumors
Novel insights into the role of microRNAs in chemoresistance, tumor progression and cancer therapy
Proton-sponge activity and receptor-targeting of sequence-defined nucleic acid carriers
Treatment of cancer with combined chemo-gene therapy based on TNFα polyplexes and liposomal doxorubicine
Mechanism of cancer evading metronomic chemotherapy and action of Archazolid as an anti-metastatic drug
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Nanocarriers based on sequence-defined oligomers for tumor-targeted siRNA and miRNA delivery
Molecularly targeted imaging and radionuclide therapy of non-thyroidal tumors following viral and non-viral sodium iodide symporter (NIS) gene delivery
Precise and multifunctional conjugates for targeted siRNA delivery
Molecular evolution assays reveal novel targets and mechanisms of drug resistance
Molecular imaging and radionuclide therapy in non-thyroidal tumors after mesenchymal stem cell- mediated sodium/iodide symporter (NIS) gene transfer
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities
Targeted RNAi and pDNA based therapy for gastrointestinal tumors
Novel insights into the role of microRNAs in chemoresistance, tumor progression and cancer therapy
Proton-sponge activity and receptor-targeting of sequence-defined nucleic acid carriers
Treatment of cancer with combined chemo-gene therapy based on TNFα polyplexes and liposomal doxorubicine